Founded in 1999, GENEART is one of the foremost global specialists in the area of Synthetic Biology. GENEART’s service portfolio is comprised of 4 fields of business, which range from the production of synthetic genes and the generation of gene variants/gene libraries in combinatorial biology (Directed Evolution) right through to the production of plasmid DNA. The entire service chain is DIN EN ISO 9001:2000 certified. As a fourth business field, GENEART offers the generation of stable mammalian cell lines and transiently transfected cells used for protein production.